Therapeutic gene correction for Lesch-Nyhan syndrome using CRISPR-mediated base and prime editing
Lesch-Nyhan syndrome (LNS) is inherited as an X-linked recessive genetic disorder caused by mutations in hypoxanthine-guanine phosphoribosyl transferase 1 (HPRT1). Patients with LNS show various clinical phenotypes, including hyperuricemia, gout, devastating behavioral abnormality, intellectual disa...
| Published in: | Molecular Therapy: Nucleic Acids |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-03-01
|
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S216225312300029X |
